These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23474929)

  • 1. Thalidomide for systemic onset juvenile idiopathic arthritis.
    Sathe K; Khubchandani RP
    Indian Pediatr; 2013 Feb; 50(2):237-9. PubMed ID: 23474929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of thalidomide in systemic onset juvenile rheumatoid arthritis.
    García-Carrasco M; Fuentes-Alexandro S; Escárcega RO; Rojas-Rodriguez J; Escobar LE
    Joint Bone Spine; 2007 Oct; 74(5):500-3. PubMed ID: 17706449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of difficult cases of systemic-onset juvenile idiopathic arthritis with tacrolimus.
    Tanaka H; Tsugawa K; Suzuki K; Oki ES; Nonaka K; Kimura S; Ito E
    Eur J Pediatr; 2007 Oct; 166(10):1053-5. PubMed ID: 17187256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anakinra: a safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA).
    Hedrich CM; Bruck N; Fiebig B; Gahr M
    Rheumatol Int; 2012 Nov; 32(11):3525-30. PubMed ID: 22083619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapies for the treatment of juvenile rheumatoid arthritis (juvenile idiopathic arthritis).
    Agle LM; Rosenkranz M; Lehman TJ
    Expert Opin Investig Drugs; 2003 Jan; 12(1):19-28. PubMed ID: 12517251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease.
    Cimaz R; Von Scheven A; Hofer M
    Swiss Med Wkly; 2012; 142():w13582. PubMed ID: 22573189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of biologics on disease course in systemic onset juvenile idiopathic arthritis.
    Baris HE; Anderson E; Sozeri B; Dedeoglu F
    Clin Rheumatol; 2018 Dec; 37(12):3263-3273. PubMed ID: 30238379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocytapheresis for the treatment of refractory systemic-onset juvenile idiopathic arthritis.
    Tanaka H; Tsugawa K; Nakahata T; Suzuki K; Ito E
    Clin Rheumatol; 2007 Jun; 26(6):1014-6. PubMed ID: 16565893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide in systemic onset Juvenile idiopathic arthritis.
    Jahan A; Dewan V; Yadav TP
    Indian Pediatr; 2012 Sep; 49(9):750-2. PubMed ID: 23024081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis.
    Juneja M; Jain R; Mishra D
    Kathmandu Univ Med J (KUMJ); 2009; 7(28):411-3. PubMed ID: 20502084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
    Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Isupova EA; Kuchinskaya EM; Glebova NI; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
    Pediatr Rheumatol Online J; 2015; 13():4. PubMed ID: 25685108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile idiopathic arthritis with peripheral gangrene.
    Ghosh JB; Gupta D; Chattopadhyay N
    Indian J Pediatr; 2006 Aug; 73(8):739-41. PubMed ID: 16936372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian comparative effectiveness study of four consensus treatment plans for initial management of systemic juvenile idiopathic arthritis: FiRst-Line Options for Systemic juvenile idiopathic arthritis Treatment (FROST).
    Nigrovic PA; Beukelman T; Tomlinson G; Feldman BM; Schanberg LE; Kimura Y;
    Clin Trials; 2018 Jun; 15(3):268-277. PubMed ID: 29542334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis.
    Adams A; Lehman TJ
    Curr Opin Rheumatol; 2005 Sep; 17(5):612-6. PubMed ID: 16093841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report.
    Iacono A; Sprocati M; Giuliani AL; Di Virgilio F; Borgna-Pignatti C; Maggiore G
    Ital J Pediatr; 2019 Jun; 45(1):73. PubMed ID: 31234906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile Idiopathic Arthritis.
    Barut K; Adrovic A; Şahin S; Kasapçopur Ö
    Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab use in young adults diagnosed with juvenile idiopathic arthritis unresponsive to conventional treatment: report of 6 cases.
    Sakamoto AP; Pinheiro MM; Barbosa CM; Fraga MM; Len CA; Terreri MT
    Rev Bras Reumatol; 2015; 55(6):536-41. PubMed ID: 26066294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept in four children with therapy-resistant systemic juvenile idiopathic arthritis.
    ten Cate R; van Suijlekom-Smit LW; Brinkman DM; Bekkering WP; Jansen-van Wijngaarden CJ; Vossen JM
    Rheumatology (Oxford); 2002 Feb; 41(2):228-9. PubMed ID: 11886975
    [No Abstract]   [Full Text] [Related]  

  • 19. [Guidelines on biologic drugs for the treatment of children with juvenile idiopathic arthritis (JIA)].
    Bukovac LT; Vidović M; Lamot L; Perica M; Harjacek M;
    Reumatizam; 2013; 60(1):57-66. PubMed ID: 24003687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management.
    Kumar S
    Indian J Pediatr; 2016 Apr; 83(4):322-7. PubMed ID: 26916892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.